Lung Cancer Research Review, Issue 78
In this issue:
Tarlatamab in SCLC after platinum-based chemotherapy
Zongertinib in previously treated HER2-mutated NSCLC
Perioperative durvalumab, chemotherapy plus new agents for resectable NSCLC
Neoadjuvant nivolumab and platinum chemotherapy for locally advanced resectable NSCLC
Selpercatinib in RET fusion-positive NSCLC
Neoadjuvant osimertinib for resectable EGFR-mutated NSCLC
OS with neoadjuvant nivolumab + chemotherapy in lung cancer
Low-dose CT for lung cancer screening in a high-risk population
Bevacizumab and carboplatinpemetrexed ± atezolizumab for advanced pleural mesothelioma
Taletrectinib in ROS1+ NSCLC
Expert contributor
Dr Malinda Itchins BMedSc; MBBS (Hons1), FRACP
Associate Professor Malinda Itchins (BMedSci; MBBS(Hons1); FRACP; PhD) is a Thoracic Medical Oncologist at Royal North Shore Hospital and Chris O’Brien Lifehouse. She is a Clinician Researcher, Trialist, Board Director with the Clinical Oncology Society of Australia (COSA) and Advanced Non-Small Cell Lung Cancer Co-Chair on the Scientific Committee with Thoracic Oncology Group of Australasia […]
Latest Publications and Videos
Stay up to date with our latest clinical information.
Explore Research Review Publications and Videos
Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry.
Terms and Conditions
Website terms of use
By using our website, you agree to follow these terms and conditions.
Privacy policy
We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms.
Copyright and use of website content
The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use.
You cannot: copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission.
Links to third-party websites
The Research Review website may link to third-party websites for your convenience. However:
We do not endorse or approve their products, services, or actions.
We are not responsible for their content or how they operate.
There is no formal partnership between us and third parties unless we clearly state otherwise.
Disclaimer and limitation of liability
We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date.
To the fullest extent allowed by law, we are not responsible for:
Any loss, damage, or costs you may suffer from using (or being unable to use) our website.
Any decisions you make based on the information provided.
Any business losses, such as lost profits, lost data, or business interruptions.
Governing law
These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.